论文部分内容阅读
2014年4月15日至25日持续11天是广东省医疗机构第三轮基本药物遴选品规及填报采购量的期间,面对即将到来的第三轮基药采购,一些已经“缺席”第二次招标采购的药企可能要继续缺席了。受不久前爆发的广东基药腐败窝案影响,这些通过灰色路径进入基药目录的药企们有的账户被查封,有的正在接受司法调查。2013年7月,广东率先发布基药增补目录,278个的增补量被业界批判为“大跃进”的典型代表。此
April 15, 2014 to 25 for 11 days is the Guangdong Province, the third round of basic medical institutions to select products and procurement rules and procurement period, in the face of the upcoming third round of procurement of base drugs, some have been “absent ”The second tender procurement of pharmaceutical companies may want to continue absent. Affected by the recent corruption in Guangdong’s base medicine sector, some of the pharmaceutical companies that entered the list of essential drugs through the gray route were closed and some were under judicial investigation. In July 2013, Guangdong took the lead to release the supplemental catalog of essential medicines, and 278 supplements were criticized by the industry as the typical representative of the “Great Leap Forward.” this